Part: 12         Session: 145678910111213141516171819202122         Page 417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465 of 999

The National Cancer Institute is beginning, at long last, just beginning to stimulate clinical trials with combinations of drugs for the important tumors, the important killers, the solid tumors such as breast cancer, lung cancer, cancer of the colon, of the prostate and other, pancreas, and ovaries. They're just beginning, and it's really, I think it was hastened a little bit by the Lasker Awards and by the publicizing of the fact that combination chemotherapy was a success in aoute lymphatic leukemia and in Hodgkins Disease.

Why does it take --

-- so long --

Why does, it take a public recognition of the sort that you give with the awafls to emphasize some of these things?

Well, you know, people are very slow and in medicine they're very jealous of each other, and hostile to new ideas. And it's only when it seems to me the new ideas get to be considered, accepted that people go forward, and there's a feeling of acceptance when they are publicized. Don't you think? When people read about what they themselves have done and what other people have done, they somehow or other get used to the thought that it's something important, that could be translated into another type of tumor. You'd think that was self evident to anybody.

But it's also been that the doctors, that the surgeons have been very difficult about allowing workers in chemotherapy